Holen Sie sich die Stockscreener-App
88.17
1.18%
-1.05
Handel nachbörslich:
88.17
Schlusskurs vom Vortag:
$89.22
Offen:
$89.24
24-Stunden-Volumen:
539.18K
Relative Volume:
0.91
Marktkapitalisierung:
$4.46B
Einnahmen:
$1.33B
Nettoeinkommen (Verlust:
$114.89M
KGV:
35.41
EPS:
2.49
Netto-Cashflow:
$70.97M
1W Leistung:
-3.53%
1M Leistung:
+15.78%
6M Leistung:
-7.90%
1J Leistung:
+5.96%
1-Tages-Spanne:
$88.15
$89.73
1-Wochen-Bereich:
$88.15
$94.98
52-Wochen-Spanne:
$70.25
$97.97
Haemonetics Corp Stock (HAE) Company Profile
Firmenname
Haemonetics Corp
Sektor
Telefon
(781) 848-7100
Adresse
125 SUMMER STREET, BOSTON, MA
Vergleichen Sie HAE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| HAE | 88.17 | 4.46B | 1.33B | 114.89M | 70.97M | 2.49 |
| ISRG | 531.64 | 190.09B | 7.87B | 2.24B | 586.00M | 4.25 |
| BDX | 224.10 | 65.14B | 20.18B | 1.73B | 3.07B | 5.51 |
| ALC | 85.81 | 42.44B | 9.76B | 1.16B | 665.00M | 0.72 |
| RMD | 239.42 | 34.99B | 4.81B | 1.11B | 1.35B | 6.16 |
| WST | 307.21 | 22.29B | 2.88B | 499.60M | 321.60M | 7.41 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-01-27 | Herabstufung | Needham | Buy → Hold |
| 2021-12-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-08-17 | Fortgesetzt | Raymond James | Outperform |
| 2021-06-17 | Eingeleitet | Citigroup | Buy |
| 2021-05-14 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | Herabstufung | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | Hochstufung | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | Eingeleitet | Needham | Buy |
| 2019-08-07 | Bestätigt | Barrington Research | Outperform |
| 2019-05-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | Bestätigt | Barrington Research | Outperform |
| 2018-08-09 | Bestätigt | Barrington Research | Outperform |
| 2018-02-07 | Bestätigt | Barrington Research | Outperform |
| 2018-01-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | Bestätigt | Barrington Research | Outperform |
| 2017-08-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | Bestätigt | The Benchmark Company | Hold |
| 2016-09-20 | Herabstufung | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | Herabstufung | Sidoti | Buy → Neutral |
| 2016-08-02 | Bestätigt | Jefferies | Buy |
| 2016-08-02 | Bestätigt | The Benchmark Company | Hold |
Alle ansehen
Haemonetics Corp Aktie (HAE) Neueste Nachrichten
Principal Financial Group Inc. Reduces Stock Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics (NYSE:HAE) Given Buy Rating at Needham & Company LLC - MarketBeat
Royce & Associates LP Has $97.30 Million Position in Haemonetics Co. (NYSE:HAE) - MarketBeat
Aigen Investment Management LP Makes New Investment in Haemonetics Co. (NYSE:HAE) - MarketBeat
T. Rowe Price Investment Management, Inc. Expands Stake in Haemo - GuruFocus.com
Capital Research Global Investors Adjusts Stake in Haemonetics C - GuruFocus.com
Here's Why Haemonetics (HAE) is a Strong Value Stock - Yahoo Finance
Blood Recovery Machine Market is expected to reach revenue of USD 4,277.4 Mn by 2033, at 5.9% CAGR: Dimension Market Research. - GlobeNewswire Inc.
Wall Street Analysts Think Haemonetics (HAE) Could Surge 25.58%: Read This Before Placing a Bet - Yahoo Finance
Haemonetics Corporation (NYSE:HAE) Q2 2025 Earnings Call Transcript - Insider Monkey
Haemonetics' Q2 Earnings and Revenues Top, Stock Up, Margins Expand - Yahoo Finance
Barrington Research Reaffirms Outperform Rating for Haemonetics (NYSE:HAE) - MarketBeat
Haemonetics (NYSE:HAE) Issues Quarterly Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
Creative Planning Reduces Stock Holdings in Haemonetics Co. (NYSE:HAE) - Defense World
Raymond James Upgrades Haemonetics (HAE) - MSN
Raymond James upgrades haemonetics stock, highlights overlooked growth drivers - Investing.com
Wellington Management Group LLP Increases Stake in Haemonetics C - GuruFocus.com
Haemonetics (NYSE:HAE) Raised to Strong-Buy at Raymond James - MarketBeat
Deep Dive Into Haemonetics Stock: Analyst Perspectives (7 Ratings) - Benzinga
Haemonetics: Fiscal Q2 Earnings Snapshot - Houston Chronicle
Haemonetics earnings beat by $0.05, revenue topped estimates - Investing.com
Haemonetics (NYSE:HAE) Shares Gap UpStill a Buy? - MarketBeat
Haemonetics Corp (HAE) Shares Up 10.58% on Nov 7 - GuruFocus.com
Haemonetics (HAE) Shares Cross Above 200 DMA - Nasdaq
Haemonetics (NYSE:HAE) Issues FY25 Earnings Guidance - MarketBeat
Compared to Estimates, Haemonetics (HAE) Q2 Earnings: A Look at Key Metrics - Yahoo Canada Finance
Haemonetics Corp Q2 FY2025 Earnings: Revenue Hits $345.5M, EPS a - GuruFocus.com
Haemonetics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended September 28, 2024 - Marketscreener.com
Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website - Quantisnow
Haemonetics Corp (HAE) Q2 2025 Earnings Report Preview: What To Expect - GuruFocus.com
Harbor Capital Advisors Inc. Acquires 30,389 Shares of Haemonetics Co. (NYSE:HAE) - MarketBeat
F M Investments LLC Purchases New Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Assenagon Asset Management S.A. Cuts Stock Position in Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics Co. (NYSE:HAE) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Haemonetics stock hits 52-week low at $70.5 amid challenges - Investing.com
Haemonetics (HAE) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
Haemonetics (HAE) to Release Quarterly Earnings on Thursday - MarketBeat
Haemonetics (HAE) Set to Announce Quarterly Earnings on Thursday - Defense World
Boston Trust Walden Corp Increases Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Riverwater Partners LLC Acquires 29,109 Shares of Haemonetics Co. (NYSE:HAE) - MarketBeat
Creative Planning Makes New Investment in Haemonetics Co. (NYSE:HAE) - Defense World
Potential Price Increase for Haemonetics Corp. (HAE) After Recent Insider Activity - Knox Daily
Northwestern Mutual Wealth Management Co. Sells 161 Shares of Haemonetics Co. (NYSE:HAE) - Defense World
Are Haemonetics Corp. (HAE) shares a good deal now? - US Post News
Balance Sheet Dive: Haemonetics Corp. (HAE)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Blood Collection Devices Global Market 2024, with Profiles of Abbott, Becton, Dickinson, FL Medical, Fresenius, Greiner Bio-One, Haemonetics, Medtronic, Nipro Medical, Qiagen, Sarstedt & Terumo BCT - Yahoo Finance
Haemonetics Corp (HAE) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges - Yahoo Finance
Q2 2025 EPS Estimates for Haemonetics Co. (NYSE:HAE) Cut by Analyst - MarketBeat
Get in on Haemonetics Corp.’s (HAE) buy-in window today! - SETE News
Robust Plasma Sales, New Innovations Aid Haemonetics Stock - Yahoo Finance
Squarepoint Ops LLC Sells 34,579 Shares of Haemonetics Co. (NYSE:HAE) - MarketBeat
Finanzdaten der Haemonetics Corp-Aktie (HAE)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.70%
3.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):